- Dawn Richards
- Vice President ,Director of Patient & Public Engagement, Clinical Trials Ontario
- Canadian Arthritis Patient Alliance, Canada
Dawn Richards, PhD, is the founder of Five02 Labs Inc, and Director of Patient and Public Engagement at Clinical Trials Ontario. She has a PhD (Analytical Chemistry, University of Alberta) and experience in a variety of roles during the past 15 years. It is really her diagnosis with rheumatoid arthritis eleven years ago that instigated a journey to combine her passion for science with making the most of her diagnosis. In her role at CTO, Dawn is charged with executing on CTO’s strategic pillar of patient and public engagement.
As a person who lives with rheumatoid arthritis, patient advocate, and volunteer, Dawn is Vice President of the Canadian Arthritis Patient Alliance, a Research Ambassador for the Institute of Musculoskeletal Health and Arthritis (of the Canadian Institutes for Health Research), and a member of The BMJ’s Patient Panel Reviewers, and was the first Patient Advisor of the Canadian Medical Association’s Wait Time Alliance. She advocates for arthritis awareness, access to treatment, the inclusion of patients in decision-making and as research collaborators, and the importance of research.